Find Imiquimod manufacturers, exporters & distributors on PharmaCompass

Interquim Imiquimod

Contact Supplier

Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

Contact Supplier

Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

Contact Supplier

Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

Contact Supplier

Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

Contact Supplier

xyz-pharma-m-2025-01-20

Contact Supplier

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

23 API Suppliers, 14 USDMF, 4 EU WC, 1 KDMF, 12 NDC API, 13 Listed Suppliers, $ API Reference Price

23 API Suppliers
14 USDMF
4 EU WC
1 KDMF
12 NDC API
13 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

3 Drugs in Development

3 Drugs in Development

INTERMEDIATES

4 Intermediates Suppliers

4 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

46 FDF Dossiers, 13 FDA Orange Book, 10 Europe, 4 Canada, 11 Australia, 3 South Africa, 5 Listed Dossiers

46 FDF Dossiers
13 FDA Orange Book
10 Europe
4 Canada
11 Australia
3 South Africa
5 Listed Dossiers

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 3 DKSH, 1 Pharm-RX Chemical, 4 Nanjing Well Pharmaceutical, 3 Actylis, 4 BASF, 1 Finar, 2 Gangwal Chemicals, 1 Kerry, 1 Microlex e.U, 1 Pluviaendo, 2 Seppic

relatedExcipients
1 Rochem International Inc
3 DKSH
1 Pharm-RX Chemical
4 Nanjing Well Pharmaceutical
3 Actylis
4 BASF
1 Finar
2 Gangwal Chemicals
1 Kerry
1 Microlex e.U
1 Pluviaendo
2 Seppic

EXCIPIENTS BY APPLICATIONS

13 Topical, 8 Solubilizers, 6 Thickeners and Stabilizers, 6 Emulsifying Agents, 5 Parenteral, 4 Surfactant & Foaming Agents, 2 Rheology Modifiers, 1 API Stability Enhancers, 1 Film Formers & Plasticizers, 1 Granulation, 1 Controlled & Modified Release, 1 Direct Compression, 1 Lubricants & Glidants, 1 Coating Systems & Additives

excipientsByApplications
13 Topical
8 Solubilizers
6 Thickeners and Stabilizers
6 Emulsifying Agents
5 Parenteral
4 Surfactant & Foaming Agents
2 Rheology Modifiers
1 API Stability Enhancers
1 Film Formers & Plasticizers
1 Granulation
1 Controlled & Modified Release
1 Direct Compression
1 Lubricants & Glidants
1 Coating Systems & Additives

DIGITAL CONTENT

2 DATA COMPILATION #PharmaFlow, 4 NEWS #PharmaBuzz

media
2 DATA COMPILATION #PharmaFlow
4 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 14 Finished Drug Prices

globalSalesInformation
2 US Medicaid Prescriptions
14 Finished Drug Prices

MARKET PLACE

4 APIs, 1 FDF Dossiers

marketPlace
4 APIs
1 FDF Dossiers

PATENTS & EXCLUSIVITIES

18 US Patents, 4 Health Canada Patents

patents
18 US Patents
4 Health Canada Patents

REF. STANDARDS & IMPURITIES

6 USP , 5 Others

otherSolutions
6 USP
5 Others

Imiquimod

Synopsis

ACTIVE PHARMA INGREDIENTS

23

API Suppliers

14

USDMF

0

CEP/COS

CEP/COS Certifications

0

JDMF

4

EU WC

1

KDMF

12

NDC API

0

VMF

13

Listed Suppliers

API REF. PRICE (USD/KG)

$

$ 2,765

MARKET PLACE

4

API

1

FDF

4INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

46

FDF Dossiers

13

FDA Orange Book

FDA (Orange Book)

10

Europe

4

Canada

11

Australia

3

South Africa

5

Listed Dossiers

3DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

6

USP

0

JP

5

Others

PATENTS & EXCLUSIVITIES

18

US Patents

0

US Exclusivities

4

Health Canada Patents

DIGITAL CONTENT

2

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

4

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

8,359,819

Annual Reports (USD Million)

NA

Finished Drug Prices

24 RELATED EXCIPIENT COMPANIES

51EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Click the button for full data set

Also known as: 99011-02-6, Aldara, Zyclara, 1-isobutyl-1h-imidazo[4,5-c]quinolin-4-amine, 1-(2-methylpropyl)-1h-imidazo[4,5-c]quinolin-4-amine, Beselna

Molecular Formula

C₁₄H₁₆N₄

Molecular Weight

240.30 g/mol

InChI Key

DOUYETYNHWVLEO-UHFFFAOYSA-N

FDA UNII

P1QW714R7M

Imiquimod

A topically-applied aminoquinoline immune modulator that induces interferon production. It is used in the treatment of external genital and perianal warts, superficial CARCINOMA, BASAL CELL; and ACTINIC KERATOSIS.

The mechanism of action of imiquimod is as an Interferon Inducer. The physiologic effect of imiquimod is by means of Increased Cytokine Activity, and Increased Cytokine Production.

1 2D Structure

Imiquimod

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

1-(2-methylpropyl)imidazo[4,5-c]quinolin-4-amine

2.1.2 InChI

InChI=1S/C14H16N4/c1-9(2)7-18-8-16-12-13(18)10-5-3-4-6-11(10)17-14(12)15/h3-6,8-9H,7H2,1-2H3,(H2,15,17)

2.1.3 InChI Key

DOUYETYNHWVLEO-UHFFFAOYSA-N

2.1.4 Canonical SMILES

CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N

2.2 Other Identifiers

2.2.1 UNII

P1QW714R7M

2.3 Synonyms

2.3.1 MeSH Synonyms

1. 1-isobutyl-1h-imidazo(4,5-c)quinolin-4-amine

2. Aldara

3. R 837

4. R-837

5. R837

6. S 26308

7. S-26308

8. Zyclara

2.3.2 Depositor-Supplied Synonyms

1. 99011-02-6

2. Aldara

3. Zyclara

4. 1-isobutyl-1h-imidazo[4,5-c]quinolin-4-amine

5. 1-(2-methylpropyl)-1h-imidazo[4,5-c]quinolin-4-amine

6. Beselna

7. 4-amino-1-isobutyl-1h-imidazo[4,5-c]quinoline

8. R 837

9. 1-(2-methylpropyl)imidazo[4,5-c]quinolin-4-amine

10. 4-amino-1-isobutyl-1h-imidazo(4,5-c)quinoline

11. 9050-31-1

12. R-837

13. S-26308

14. C14h16n4

15. Mfcd00866946

16. Tmx-101

17. S26308

18. Nsc-369100

19. Nsc-759651

20. Chembl1282

21. 1-isobutylimidazo[4,5-c]quinolin-4-amine

22. P1qw714r7m

23. 1h-imidazo(4,5-c)quinolin-4-amine, 1-(2-methylpropyl)-

24. 1h-imidazo[4,5-c]quinolin-4-amine, 1-(2-methylpropyl)-

25. Chebi:36704

26. Ncgc00070736-02

27. Zartra

28. Imiquimod Acetate

29. Dsstox_cid_21047

30. Dsstox_rid_79617

31. Dsstox_gsid_41047

32. Aldara (tn)

33. Cas-99011-02-6

34. S 26308

35. Sr-01000611320

36. 1-(2-methylpropyl)-1h-imidazole[4,5-c]quinoline-4-amine

37. Unii-p1qw714r7m

38. Imiquimodum

39. Imiquimod [usan:inn:ban]

40. Vyloma

41. Mtd-39

42. Hsdb 8129

43. Tmx 101

44. Imiquimod,(s)

45. Imiquimod- Bio-x

46. 6t0

47. Imiquimod - Aldara

48. Zyclara (tn)

49. Dz-2636

50. R837

51. Imiquimod [inn]

52. Imiquimod [jan]

53. Imiquimod [mi]

54. Imiquimod [usan]

55. Imiquimod [vandf]

56. Imiquimod [mart.]

57. (non-labelled)imiquimod-d9

58. Imiquimod [usp-rs]

59. Imiquimod [who-dd]

60. Imiquimod (jan/usp/inn)

61. Schembl26136

62. Imiquimod [ema Epar]

63. Mls000083577

64. Bidd:gt0859

65. Gtpl5003

66. Imiquimod [orange Book]

67. Dtxsid7041047

68. Imiquimod [usp Monograph]

69. Hms2090m14

70. Hms2232g07

71. Hms3373b13

72. Hms3715n19

73. Hms3747a13

74. Pharmakon1600-01502351

75. Bcp05151

76. Hy-b0180

77. Tox21_110985

78. Ac-529

79. Bbl010772

80. Bdbm50240849

81. Nsc369100

82. Nsc759651

83. Nsc811538

84. S1211

85. Stk583860

86. Zinc19632912

87. Imiquimod - Cas 99011-02-6

88. Imiquimod, >=98% (hplc), Solid

89. Akos005507352

90. Cellulose, Hydrogen 1,2-benzenedicarboxylate, 2-hydroxypropyl Methyl Ether

91. Tox21_110985_1

92. 1h-imidazo[4, 1-(2-methylpropyl)-

93. Ccg-208015

94. Cs-2058

95. Db00724

96. Ks-5218

97. Nsc 369100

98. Nsc 741062

99. Nsc 759651

100. Nsc-811538

101. Yh44175

102. (hydroxypropyl)methyl Cellulose Phthalate

103. Imiquimod 100 Microg/ml In Acetonitrile

104. Ncgc00070736-03

105. Ncgc00070736-04

106. Bi164576

107. Smr000048307

108. Sy017571

109. Ft-0602727

110. I0747

111. D02500

112. 1-isobutyl-1h-imidazo [4,5-c]quinolin-4-amine

113. 1-isobutyl-1h-imidazo[4,5-c]quinoline-4-amine

114. Ab00399298-05

115. Ab00399298-06

116. Ab00399298-07

117. Ab00399298_08

118. Ab00399298_09

119. 011i026

120. 1-isobutyl-1h-imidazo[4,5-c]quinolin-4-ylamine

121. A845945

122. Q423417

123. 1-(2-methylpropyl)-4-imidazo[4,5-c]quinolinamine

124. Sr-01000611320-2

125. Sr-01000611320-3

126. Brd-k26657438-001-01-2

127. Brd-k26657438-001-13-7

128. 1-(2-methylpropyl)-1himidazo[4,5-c]quinolin-4-amine

129. 1-(2-methylpropyl)-1h-imidazo[4,5-c]-quinolin-4-amine

130. Imiquimod, United States Pharmacopeia (usp) Reference Standard

2.4 Create Date

2005-06-29

3 Chemical and Physical Properties

Molecular Formula	C₁₄H₁₆N₄
Molecular Weight	240.30 g/mol
XLogP3	2.6
Hydrogen Bond Donor Count	1
Hydrogen Bond Acceptor Count	3
Rotatable Bond Count	2
Exact Mass	240.137496527 g/mol
Monoisotopic Mass	240.137496527 g/mol
Topological Polar Surface Area	56.7 Å²
Heavy Atom Count	18
Formal Charge	0
Complexity	294
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1

4 Drug and Medication Information

4.1 Drug Information

1 of 6
Drug Name	Aldara
PubMed Health	Imiquimod (On the skin)
Drug Classes	Immune Modulator
Drug Label	Aldara (imiquimod 5%) Cream is an immune response modifier for topical administration. Each gram contains 50 mg of imiquimod in an off-white oil-in-water vanishing cream base consisting of isostearic acid, cetyl alcohol, stearyl alcohol, white petrol...
Active Ingredient	Imiquimod
Dosage Form	Cream
Route	Topical
Strength	5%
Market Status	Prescription
Company	Medicis

2 of 6
Drug Name	Imiquimod
PubMed Health	Imiquimod (On the skin)
Drug Classes	Immune Modulator
Drug Label	Aldara (imiquimod 5%) Cream is an immune response modifier for topical administration. Each gram contains 50 mg of imiquimod in an off-white oil-in-water vanishing cream base consisting of isostearic acid, cetyl alcohol, stearyl alcohol, white petrol...
Active Ingredient	Imiquimod
Dosage Form	Cream
Route	Topical
Strength	5%
Market Status	Prescription
Company	Apotex; Teva Pharms Usa; Taro; Strides Pharma; Glenmark Generics; Fougera Pharms; Tolmar; Perrigo Israel

3 of 6
Drug Name	Zyclara
PubMed Health	Imiquimod (On the skin)
Drug Classes	Immune Modulator
Drug Label	ZYCLARA (imiquimod) Cream, 2.5% or 3.75% is intended for topical administration. Each gram contains 25 mg or 37.5 mg of imiquimod, respectively, in a white to faintly yellow oil-in-water cream base consisting of isostearic acid, cetyl alcohol, steary...
Active Ingredient	Imiquimod
Dosage Form	Cream
Route	topical; Topical
Strength	3.75%; 2.5%
Market Status	Prescription
Company	Medicis; Graceway

4 of 6
Drug Name	Aldara
PubMed Health	Imiquimod (On the skin)
Drug Classes	Immune Modulator
Drug Label	Aldara (imiquimod 5%) Cream is an immune response modifier for topical administration. Each gram contains 50 mg of imiquimod in an off-white oil-in-water vanishing cream base consisting of isostearic acid, cetyl alcohol, stearyl alcohol, white petrol...
Active Ingredient	Imiquimod
Dosage Form	Cream
Route	Topical
Strength	5%
Market Status	Prescription
Company	Medicis

5 of 6
Drug Name	Imiquimod
PubMed Health	Imiquimod (On the skin)
Drug Classes	Immune Modulator
Drug Label	Aldara (imiquimod 5%) Cream is an immune response modifier for topical administration. Each gram contains 50 mg of imiquimod in an off-white oil-in-water vanishing cream base consisting of isostearic acid, cetyl alcohol, stearyl alcohol, white petrol...
Active Ingredient	Imiquimod
Dosage Form	Cream
Route	Topical
Strength	5%
Market Status	Prescription
Company	Apotex; Teva Pharms Usa; Taro; Strides Pharma; Glenmark Generics; Fougera Pharms; Tolmar; Perrigo Israel

6 of 6
Drug Name	Zyclara
PubMed Health	Imiquimod (On the skin)
Drug Classes	Immune Modulator
Drug Label	ZYCLARA (imiquimod) Cream, 2.5% or 3.75% is intended for topical administration. Each gram contains 25 mg or 37.5 mg of imiquimod, respectively, in a white to faintly yellow oil-in-water cream base consisting of isostearic acid, cetyl alcohol, steary...
Active Ingredient	Imiquimod
Dosage Form	Cream
Route	topical; Topical
Strength	3.75%; 2.5%
Market Status	Prescription
Company	Medicis; Graceway

4.2 Therapeutic Uses

Adjuvants, Immunologic; Antineoplastic Agents

National Library of Medicine's Medical Subject Headings online file (MeSH, 2013)

Imiquimod is used topically for the treatment of clinically typical, nonhyperkeratotic, nonhypertrophic actinic keratosis on the face or scalp in immunocompetent adults; treatment of biopsy-confirmed, primary superficial basal cell carcinoma in immunocompetent adults; and treatment of external genital and perianal exophytic warts (condylomata acuminata) caused by human papillomavirus (HPV). /Included in US product label/

American Society of Health-System Pharmacists 2012; Drug Information 2012. Bethesda, MD. 2012, p. 3577

Topical imiquimod has been effective when used in a limited number of adults and children for the treatment of molluscum contagiosum. /NOT included in US product label/

American Society of Health-System Pharmacists 2012; Drug Information 2012. Bethesda, MD. 2012, p. 3578

Imiquimod 5% cream has been used for the topical treatment of external genital and perianal HPV warts in a limited number of adults with human immunodeficiency virus (HIV) infection; however, the response rate appears to be lower in these individuals than in those who are not HIV infected. /NOT included in US product label/

American Society of Health-System Pharmacists 2012; Drug Information 2012. Bethesda, MD. 2012, p. 3578

For more Therapeutic Uses (Complete) data for Imiquimod (6 total), please visit the HSDB record page.

4.3 Drug Warning

Adverse local reactions, including erythema, erosion, excoriation/flaking, and edema, commonly occur at the site of application of imiquimod and/or surrounding areas. These reactions usually are mild to moderate in severity; however, severe local reactions have been reported.

American Society of Health-System Pharmacists 2012; Drug Information 2012. Bethesda, MD. 2012, p. 3578

In controlled studies in adults with actinic keratosis, the most frequently reported local skin reactions in those receiving imiquimod 5% cream (twice weekly for 16 weeks) were erythema (97%), flaking/scaling/dryness (93%), scabbing/crusting (79%), edema (49%), erosion/ulceration (48%), weeping/exudate (22%), and vesicles (9%).1 Application site reactions (e.g., bleeding, burning, induration, irritation, pain, pruritus, stinging, tenderness) occurred in 33% of those receiving topical imiquimod compared with 14% of those receiving placebo. In these studies, 16% of patients discontinued imiquimod treatment because of local or application site reactions and 91% of these were able to resume treatment after a rest period.

American Society of Health-System Pharmacists 2012; Drug Information 2012. Bethesda, MD. 2012, p. 3578

Adverse dermatologic reactions at sites away from the site of application have been reported in some patients receiving topical imiquimod. Remote site reactions have included bleeding, burning, edema, erosion, erythema, excoriation/flaking, induration, pain, pruritus, tenderness, tinea cruris, and ulceration.

American Society of Health-System Pharmacists 2012; Drug Information 2012. Bethesda, MD. 2012, p. 3579

When imiquimod 5% cream was used in controlled studies in patients with genital and perianal HPV warts (3 times weekly for up to 16 weeks), erythema occurred in 58-65%, erosion in 30-31%, excoriation/flaking in 18-26%, edema in 12-18%, scabbing in 4-13%, induration in 5-7%, ulceration in 4-8%, and vesicles in 2-3% of those receiving the drug.1 In addition, application site reactions in those receiving the drug included pruritus (22-32%), burning (9-26%), pain (2-8%), and soreness (0-3%). In addition, fungal infections occurred in 2-11% of patients receiving the drug. Overall, 1.2% of patients in these studies discontinued treatment because of local or application site reactions.

American Society of Health-System Pharmacists 2012; Drug Information 2012. Bethesda, MD. 2012, p. 3579

For more Drug Warnings (Complete) data for Imiquimod (25 total), please visit the HSDB record page.

4.4 Drug Indication

For the topical treatment of clinically typical, nonhyperkeratotic, nonhypertrophic actinic keratoses on the face or scalp in immunocompetent adults. Also indicated for the treatment of external genital and perianal warts/condyloma acuminata in individuals 12 years old and above.

FDA Label

Zyclara is indicated for the topical treatment of clinically typical, non-hyperkeratotic, non-hypertrophic, visible or palpable actinic keratosis of the full face or balding scalp in immunocompetent adults when other topical treatment options are contraindicated or less appropriate.

Imiquimod cream is indicated for the topical treatment of:

- external genital and perianal warts (condylomata acuminata) in adults;

- small superficial basal-cell carcinomas (sBCCs) in adults;

- clinically typical, non-hyperkeratotic, non-hypertrophic actinic keratoses (AKs) on the face or scalp in immunocompetent adult patients when size or number of lesions limit the efficacy and / or acceptability of cryotherapy and other topical treatment options are contraindicated or less appropriate.

Imiquimod cream is indicated for the topical treatment of external genital and perianal warts (condyloma acuminata) in adult patients.

5 Pharmacology and Biochemistry

5.1 Pharmacology

Imiquimod is an immune response modifier that acts as a toll-like receptor 7 agonist. Imiquimod is commonly used topically to treat warts on the skin of the genital and anal areas. Imiquimod does not cure warts, and new warts may appear during treatment. Imiquimod does not fight the viruses that cause warts directly, however, it does help to relieve and control wart production. It is not used on warts inside the vagina, penis, or rectum. Imiquimod is also used to treat a skin condition of the face and scalp called actinic keratoses. Imiquimod can also be used to treat certain types of skin cancer called superficial basal cell carcinoma. Imiquimod is particularly useful on areas where surgery or other treatments may be difficult, complicated or otherwise undesirable, especially the face and lower legs.

5.2 MeSH Pharmacological Classification

Adjuvants, Immunologic

Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. (See all compounds classified as Adjuvants, Immunologic.)

Antineoplastic Agents

Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)

Interferon Inducers

Agents that promote the production and release of interferons. They include mitogens, lipopolysaccharides, and the synthetic polymers Poly A-U and Poly I-C. Viruses, bacteria, and protozoa have been also known to induce interferons. (See all compounds classified as Interferon Inducers.)

5.3 FDA Pharmacological Classification

5.3.1 Active Moiety

IMIQUIMOD

5.3.2 FDA UNII

P1QW714R7M

5.3.3 Pharmacological Classes

Increased Cytokine Production [PE]; Interferon Inducers [MoA]; Increased Cytokine Activity [PE]

5.4 ATC Code

D06BB10

D06BB10

L03AX

D06BB10

S76 | LUXPHARMA | Pharmaceuticals Marketed in Luxembourg | Pharmaceuticals marketed in Luxembourg, as published by d'Gesondheetskeess (CNS, la caisse nationale de sante, www.cns.lu), mapped by name to structures using CompTox by R. Singh et al. (in prep.). List downloaded from https://cns.public.lu/en/legislations/textes-coordonnes/liste-med-comm.html. Dataset DOI:10.5281/zenodo.4587355

D - Dermatologicals

D06 - Antibiotics and chemotherapeutics for dermatological use

D06B - Chemotherapeutics for topical use

D06BB - Antivirals

D06BB10 - Imiquimod

5.5 Absorption, Distribution and Excretion

Absorption

Well absorbed through skin (as a cream)

Following topical application to the skin in adults with actinic keratosis (75-mg doses 3 times weekly for 16 weeks), 0.08-0.15% of the dose is eliminated in urine as unchanged drug and metabolites. Following topical application in patients with HPV warts, 0.11 or 2.41% of the dose is eliminated in urine as unchanged drug and metabolites in men or women, respectively.

American Society of Health-System Pharmacists 2012; Drug Information 2012. Bethesda, MD. 2012, p. 3580

Imiquimod is absorbed systemically following topical application to skin. In adults with actinic keratosis who received topical imiquimod 5% cream 3 times weekly for 16 weeks, mean peak serum concentrations at the end of week 16 were approximately 0.1, 0.2, or 3.5 ng/mL in those treated on the face (12.5-mg doses), scalp (25-mg doses), or hands/arms (75-mg doses), respectively. Systemic exposure appeared to depend more on the surface area of the application site than on the total applied dose. In patients with external genital and perianal human papillomavirus (HPV) warts who received topical imiquimod 5% cream (average dose 4.6 mg), mean peak serum concentrations were 0.4 ng/mL.

American Society of Health-System Pharmacists 2012; Drug Information 2012. Bethesda, MD. 2012, p. 3580

5.6 Biological Half-Life

20 hours (topical dose), 2 hours (subcutaneous dose)

Studies using subcutaneous imiquimod indicate the drug has an apparent half-life of 2 hours. Following topical application, imiquimod appears to be retained in the skin for prolonged periods since the half-life is approximately 10 times greater than that reported following subcutaneous administration.

American Society of Health-System Pharmacists 2012; Drug Information 2012. Bethesda, MD. 2012, p. 3580

5.7 Mechanism of Action

Imiquimod's mechanism of action is via stimulation of innate and acquired immune responses, which ultimately leads to inflammatory cell infiltration within the field of drug application followed by apoptosis of diseased tissue. Imiquimod does not have direct antiviral activity. Studies of mice show that imiquimod may induce cytokines, including interferon-alpha (IFNA) as well as several IFNA genes (IFNA1, IFNA2, IFNA5, IFNA6, and IFNA8) as well as the IFNB gene. Imiquimod also induced the expression of interleukin (IL)-6, IL-8, and tumor necrosis factor alpha genes. In the treatment of basal cell carcinoma, Imiquimod appears to act as a toll-like receptor-7 agonist, and is thought to exert its anti-tumor effect via modification of the immune response and stimulation of apoptosis in BCC cells. In treating basal cell carcinoma it may increase the infiltration of lymphocytes, dendritic cells, and macrophages into the tumor lesion.

Imiquimod and resiquimod represent Toll-like receptor (TLR) 7 and 8 agonists, which emerged as attractive candidates for tumor therapy. To elucidate immune cells, which mainly contribute to TLR7/8-mediated antitumoral activity, /the researchers/ investigated the impact of imiquimod and resiquimod on native human 6-sulfo LacNAc (slan) dendritic cells (DCs). /The researchers/ found that both TLR7/8 agonists significantly improve the release of various proinflammatory cytokines by slanDCs and promote their tumor-directed cytotoxic activity. Furthermore, resiquimod efficiently augmented the ability of slanDCs to stimulate T cells and natural killer cells. These results indicate that imiquimod and resiquimod trigger various immunostimulatory properties of slanDCs, which may contribute to their antitumor effects.

PMID:23402811 Jahnisch H et al; Cancer Lett. 2013 Feb 9 (Epub ahead of print)

Aldara is a cream used for topical treatment of non-melanoma skin cancer, and is thought to act through stimulation of anti-tumour immunity. The active ingredient, imiquimod, has been shown to stimulate toll-like receptor 7. Aldara also induces psoriasis-like lesions when applied to naive murine skin, and as such is used as a mouse model for psoriasis. Here we find that in naive murine skin, Aldara induces inflammation largely independently of toll-like receptor 7. Surprisingly, inflammasome activation, keratinocyte death and interleukin 1 release also occur in response to the vehicle cream in the absence of imiquimod. We show that isostearic acid, a major component of the vehicle, promotes inflammasome activation in cultured keratinocytes, and so may contribute to the observed effects of Aldara on murine skin. Aldara therefore stimulates at least two immune pathways independently, and both imiquimod and vehicle are required for a full inflammatory response. Although it remains to be tested, it is possible that imiquimod-independent effects also contribute to the therapeutic efficacy of Aldara.

PMID:23463003 Walter A et al; Nat Commun. 2013 Mar 5;4:1560

Imiquimod is recognized as an agonist for Toll-like receptor 7 (TLR7) in immunocompetent cells. TLR7, as well as TLR3 and TLR8, triggers the immune responses, such as the production of type I interferons (IFNs) and proinflammatory cytokines via recognition of viral nucleic acids in the infected cells. In this study, /the reseachers/ proposed that imiquimod has an IFN-independent antiviral effect in nonimmune cells. Imiquimod, but not resiquimod, suppressed replication of human herpes simplex virus 1 (HSV-1) in FL cells. We analyzed alternation of gene expression by treatment with imiquimod using microarray analysis. Neither type I IFNs, nor TLRs, nor IFN-inducible antiviral genes were induced in imiquimod-treated FL cells. Cystatin A, a host cysteine protease inhibitor, was strongly upregulated by imiquimod and took a major part in the anti-HSV-1 activity deduced by the suppression experiment using its small interfering RNA. Upregulation of cystatin A was suggested to be mediated by antagonizing adenosine receptor A(1) and activating the protein kinase A pathway. Imiquimod, but not resiquimod, was shown to interact with adenosine receptor A(1). Imiquimod-induced anti-HSV-1 activity was observed in other cells, such as HeLa, SiHa, and CaSki cells, in a manner consistent with the cystatin A induction by imiquimod. These results indicated that imiquimod acted as an antagonist for adenosine receptor A(1) and induced a host antiviral protein, cystatin A. The process occurred independently of TLR7 and type I IFNs.

PMID:22787201 Full text: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3457300 Kan Y et al; J Virol 86 (19): 10338-46 (2012)

Toll-like receptor (TLR) agonists have anticancer effect by inducing apoptosis or activating immune cells. In this study, we investigated whether imiquimod, TLR7 agonist, inhibits the proliferation of oral cancer cells. Toll-like receptor 7 expression and IL-6/8 production by imiquimod were examined using RT-PCR and Enzyme-linked immunosorbent assay, respectively. Cell viability was examined by MTT assay. To examine apoptotic cell death, Annexin V/PI staining for flow cytometry and Western blot analysis were performed. Necrotic cell death was determined by leakage of lactate dehydrogenase (LDH), HMGB1, and PI staining in imiquimod-treated oral squamous cell carcinoma (OSCC) cells. Toll-like receptor 7 mRNA was expressed in OSCC cells. Imiquimod induced IL-6 and IL-8 production in OSCC cells, suggesting the functional expression of TLR7. Imiquimod inhibited cells proliferation in a dose-dependent manner. The ratio of annexin V-positive cells and cleaved caspase-3/7 was increased by imiquimod treatment in OSCC cells, suggesting that imiquimod-induced cell death in OSCC cells may be owing to apoptosis. In addition, LDH secretion and PI staining were detected in OSCC cells treated with imiquimod, showing that imiquimod also induced necrotic cell death in the OSCC cells. Imiquimod inhibited effectively the growth of OSCC cells by inducing apoptosis and necrosis.

PMID:22577802 Ahn MY et al; J Oral Pathol Med 41 (7): 540-6 (2012)

API SUPPLIERS

01

Interquim SA

Spain

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Biotech Showcase

Not Confirmed

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Contact Supplier

Spain

Digital Content

USDMF

Click Us!

CEP/COS JDMF EU-WC NDC KDMF VMF ASMF

AUDIT

Product Web Link

Digital Content

02

LGM Pharma

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Biotech Showcase

Not Confirmed

LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Contact Supplier

Contact Supplier

U.S.A

Digital Content

USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT

Product Web Link

Digital Content

03

Seqens

France

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Biotech Showcase

Not Confirmed

Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

Contact Supplier

Contact Supplier

France

Digital Content

USDMF

CEP/COS JDMF EU-WC NDC

KDMF VMF Others AUDIT

Seqens Company Banner

Product Web Link

Digital Content

04

USV Private Limited

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Biotech Showcase

Not Confirmed

USV offers custom peptide synthesis ranging from gram to multi-gram to multi-kilogram quantities.

Contact Supplier

Contact Supplier

India

Digital Content

USDMF

CEP/COS JDMF EU-WC

NDC

KDMF VMF Others AUDIT

USV Private Limited

Portfolio PDF

Product Web Link

Digital Content

05

TAPI Technology & API Services

Israel

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

CPhI WW Frankfurt

TAPI offers customized CDMO Solutions for API development and manufacturing services.

Contact Supplier

Contact Supplier

Israel

Digital Content

USDMF

CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT

TAPI Company Banner

Product Web Link

Digital Content

Corporate PDF

06

Solara Active Pharma Sciences

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Biotech Showcase

Not Confirmed

07

Taro Pharmaceutical Industries

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Biotech Showcase

Not Confirmed

08

Taro Pharmaceutical Industries

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Biotech Showcase

Not Confirmed

09

Glenmark Life Sciences

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Biotech Showcase

Not Confirmed

10

Wanbury Limited

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Biotech Showcase

Not Confirmed

Only 10 entries up to this point, click to access all

Full Screen View

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

USDMF

Full Screen View

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

EU WC

Full Screen View

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

KDMF

Full Screen View

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

NDC API

Full Screen View

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Suppliers

Full Screen View

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

API Reference Price

[{"dataSource":"API Export","activeIngredients":"IMIQUIMOD","year":"2021","qtr":"Q2","strtotime":1621362600,"product":"IMIQUIMOD - BULK DRUG","address":"PLOT 170-172, CHANDRAMOULI,INDUSTR IAL ESTATE, MOHOL BAZARPETH","city":"SOLAPUR,MAHARASHTRA","supplier":"GLENMARK PHARMACEUTICALS","supplierCountry":"INDIA","foreign_port":"MEXICO CITY","customer":"A.A. MARTIN RODRIGUEZ RUIZ","customerCountry":"MEXICO","quantity":"5.00","actualQuantity":"5","unit":"KGS","unitRateFc":"2896.3","totalValueFC":"14244.5","currency":"USD","unitRateINR":208680.20000000001,"date":"19-May-2021","totalValueINR":"1043401","totalValueInUsd":"14244.5","indian_port":"BOMBAY AIR","hs_no":"29339990","bill_no":"1870719","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"MEXICO","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"PLOT 170-172, CHANDRAMOULI,INDUSTR IAL ESTATE, MOHOL BAZARPETH, SOLAPUR,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"IMIQUIMOD","year":"2021","qtr":"Q2","strtotime":1621967400,"product":"IMIQUIMOD-USP BATCH NO:ADA000444A MFG DT :JAN 2018 RE TEST DT:DEC 2022","address":"NO.201, DEVAVRATA SECTOR 17,,VASHI , NAVI MUMBAI - 400705.","city":"NAVI MUMBAI,MAHARASHTRA","supplier":"SOLARA ACTIVE PHARMA SCIENCES","supplierCountry":"INDIA","foreign_port":"FRANKFURT\/MAIN INT\\'L","customer":"M\/S.","customerCountry":"GERMANY","quantity":"4.00","actualQuantity":"4","unit":"KGS","unitRateFc":"2911.4","totalValueFC":"11454.9","currency":"USD","unitRateINR":209765.07750000001,"date":"26-May-2021","totalValueINR":"839060.31","totalValueInUsd":"11454.9","indian_port":"BANGALORE AIR","hs_no":"29420090","bill_no":"2009858","productDescription":"API","marketType":"REGULATED MARKET","country":"GERMANY","selfForZScoreResived":"Pharma Grade","supplierPort":"BANGALORE AIR","supplierAddress":"NO.201, DEVAVRATA SECTOR 17,,VASHI , NAVI MUMBAI - 400705., NAVI MUMBAI,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q2","strtotime":1623695400,"product":"IMIQUIMOD - USP B\/N.ADA000444A MFG DT-JA N2018 RE TEST DT-DEC2022","address":"NO.201, DEVAVRATA SECTOR 17,,VASHI , NAVI MUMBAI - 400705.","city":"NAVI MUMBAI,MAHARASHTRA","supplier":"SOLARA ACTIVE PHARMA SCIENCES","supplierCountry":"INDIA","foreign_port":"TAIPEI","customer":"M\/S.","customerCountry":"TAIWAN","quantity":"1.00","actualQuantity":"1","unit":"KGS","unitRateFc":"3909.9","totalValueFC":"3830.4","currency":"USD","unitRateINR":281708.53000000003,"date":"15-Jun-2021","totalValueINR":"281708.53","totalValueInUsd":"3830.4","indian_port":"BANGALORE AIR","hs_no":"29420090","bill_no":"2420606","productDescription":"API","marketType":"REGULATED MARKET","country":"TAIWAN","selfForZScoreResived":"Pharma Grade","supplierPort":"BANGALORE AIR","supplierAddress":"NO.201, DEVAVRATA SECTOR 17,,VASHI , NAVI MUMBAI - 400705., NAVI MUMBAI,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q3","strtotime":1630348200,"product":"IMIQUIMOD - BULK DRUG","address":"PLOT 170-172, CHANDRAMOULI,INDUSTR IAL ESTATE, MOHOL BAZARPETH","city":"SOLAPUR,MAHARASHTRA","supplier":"GLENMARK PHARMACEUTICALS","supplierCountry":"INDIA","foreign_port":"MEXICO CITY","customer":"A.A. MARTIN RODRIGUEZ RUIZ","customerCountry":"MEXICO","quantity":"10.00","actualQuantity":"10","unit":"KGS","unitRateFc":"2900","totalValueFC":"28718.8","currency":"USD","unitRateINR":213000,"date":"31-Aug-2021","totalValueINR":"2130000","totalValueInUsd":"28718.8","indian_port":"BOMBAY AIR","hs_no":"29339990","bill_no":"4247810","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"MEXICO","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"PLOT 170-172, CHANDRAMOULI,INDUSTR IAL ESTATE, MOHOL BAZARPETH, SOLAPUR,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q3","strtotime":1632335400,"product":"IMIQUIMOD USP","address":"101, SAI SIDDHI BLDG, PLOTNO.264 H, SECTOR-3, AIROLI,","city":"NAVI MUMBAI, M.S.","supplier":"ZEON PHARMA INDUSTRIES INDIA PVT LTD","supplierCountry":"INDIA","foreign_port":"ASUNCION","customer":"BANCO BIBAO VIZCAYA","customerCountry":"PARAGUAY","quantity":"3.00","actualQuantity":"3","unit":"KGS","unitRateFc":"1250","totalValueFC":"3697.8","currency":"USD","unitRateINR":90666.666666666672,"date":"23-Sep-2021","totalValueINR":"272000","totalValueInUsd":"3697.8","indian_port":"BOMBAY AIR","hs_no":"29339990","bill_no":"4788969","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"PARAGUAY","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"101, SAI SIDDHI BLDG, PLOTNO.264 H, SECTOR-3, AIROLI,, NAVI MUMBAI, M.S.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q4","strtotime":1634754600,"product":"IMIQUIMOD - BULK DRUG","address":"PLOT 170-172, CHANDRAMOULI,INDUSTR IAL ESTATE, MOHOL BAZARPETH","city":"SOLAPUR,MAHARASHTRA","supplier":"GLENMARK PHARMACEUTICALS","supplierCountry":"INDIA","foreign_port":"MEXICO CITY","customer":"A.A. MARTIN RODRIGUEZ RUIZ","customerCountry":"MEXICO","quantity":"5.00","actualQuantity":"5","unit":"KGS","unitRateFc":"2900","totalValueFC":"14310.1","currency":"USD","unitRateINR":214400,"date":"21-Oct-2021","totalValueINR":"1072000","totalValueInUsd":"14310.1","indian_port":"BOMBAY AIR","hs_no":"29339990","bill_no":"5443338","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"MEXICO","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"PLOT 170-172, CHANDRAMOULI,INDUSTR IAL ESTATE, MOHOL BAZARPETH, SOLAPUR,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q4","strtotime":1639938600,"product":"IMIQUIMOD","address":"Plot 170-172, Chandramouli Industrial Estate, Mohol Bazarpeth","city":"Solapur","supplier":"GLENMARK PHARMACEUTICALS","supplierCountry":"INDIA","foreign_port":"SANTIAGO DE CHILE -","customer":"SALCOBRAND S.A","customerCountry":"CHILE","quantity":"1.00","actualQuantity":"1","unit":"KGS","unitRateFc":"2725","totalValueFC":"2717.9","currency":"USD","unitRateINR":205000,"date":"20-Dec-2021","totalValueINR":"205000","totalValueInUsd":"2717.9","indian_port":"BOMBAY AIR","hs_no":"29339990","bill_no":"6885609","productDescription":"API","marketType":"REGULATED MARKET","country":"CHILE","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"Plot 170-172, Chandramouli Industrial Estate, Mohol Bazarpeth, Solapur","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1642444200,"product":"IMIQUIMOD - BULK DRUG","address":"Plot 170-172, Chandramouli Industrial Estate, Mohol Bazarpeth","city":"Solapur","supplier":"GLENMARK PHARMACEUTICALS","supplierCountry":"INDIA","foreign_port":"ASUNCION","customer":"QUIMFA S.A.","customerCountry":"PARAGUAY","quantity":"5.00","actualQuantity":"5","unit":"KGS","unitRateFc":"1460","totalValueFC":"7208.7","currency":"USD","unitRateINR":107400,"date":"18-Jan-2022","totalValueINR":"537000","totalValueInUsd":"7208.7","indian_port":"BOMBAY AIR","hs_no":"29339990","bill_no":"7555498","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"PARAGUAY","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"Plot 170-172, Chandramouli Industrial Estate, Mohol Bazarpeth, Solapur","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1643826600,"product":"IMIQUIMOD","address":"PLOT 170-172, CHANDRAMOULI,INDUSTR","city":"SOLAPUR,MAHARASHTRA","supplier":"GLENMARK PHARMACEUTICALS","supplierCountry":"INDIA","foreign_port":"MONTEVIDEO","customer":"NPS URUGUAY S.A.","customerCountry":"URUGUAY","quantity":"23.00","actualQuantity":"23","unit":"KGS","unitRateFc":"1330","totalValueFC":"30036.2","currency":"USD","unitRateINR":97888,"date":"03-Feb-2022","totalValueINR":"2251424","totalValueInUsd":"30036.2","indian_port":"Dahez-SEZ","hs_no":"29339990","bill_no":"4001598","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"URUGAY","selfForZScoreResived":"Pharma Grade","supplierPort":"Dahez-SEZ","supplierAddress":"PLOT 170-172, CHANDRAMOULI,INDUSTR, SOLAPUR,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1644345000,"product":"IMIQUIMOD","address":"Plot 170-172, Chandramouli Industrial Estate, Mohol Bazarpeth","city":"Solapur","supplier":"GLENMARK PHARMACEUTICALS","supplierCountry":"INDIA","foreign_port":"SANTIAGO DE CHILE -","customer":"SALCOBRAND S.A","customerCountry":"CHILE","quantity":"1.00","actualQuantity":"1","unit":"KGS","unitRateFc":"2725","totalValueFC":"2361.4","currency":"USD","unitRateINR":177000,"date":"09-Feb-2022","totalValueINR":"177000","totalValueInUsd":"2361.4","indian_port":"BOMBAY AIR","hs_no":"29339990","bill_no":"8087755","productDescription":"API","marketType":"REGULATED MARKET","country":"CHILE","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"Plot 170-172, Chandramouli Industrial Estate, Mohol Bazarpeth, Solapur","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1648405800,"product":"IMIQUIMOD","address":"PLOT 170-172, CHANDRAMOULI,INDUSTR","city":"SOLAPUR,MAHARASHTRA","supplier":"GLENMARK PHARMACEUTICALS","supplierCountry":"INDIA","foreign_port":"BUENOS AIRES","customer":"CONDERCO S.A.","customerCountry":"ARGENTINA","quantity":"20.00","actualQuantity":"20","unit":"KGS","unitRateFc":"1290.1","totalValueFC":"25456.9","currency":"USD","unitRateINR":97015.5,"date":"28-Mar-2022","totalValueINR":"1940310","totalValueInUsd":"25456.9","indian_port":"Dahez-SEZ","hs_no":"29339990","bill_no":"4004067","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"ARGENTINA","selfForZScoreResived":"Pharma Grade","supplierPort":"Dahez-SEZ","supplierAddress":"PLOT 170-172, CHANDRAMOULI,INDUSTR, SOLAPUR,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q2","strtotime":1653935400,"product":"IMIQUIMOD *LUT ARN NO. AD240322035753E D","address":"Plot 170-172, Chandramouli Industrial Estate, Mohol Bazarpeth","city":"Solapur","supplier":"GLENMARK PHARMACEUTICALS","supplierCountry":"INDIA","foreign_port":"MEXICO CITY","customer":"TO THE ORDER","customerCountry":"MEXICO","quantity":"5.00","actualQuantity":"5","unit":"KGS","unitRateFc":"2900","totalValueFC":"14414","currency":"USD","unitRateINR":222800,"date":"31-May-2022","totalValueINR":"1114000","totalValueInUsd":"14414","indian_port":"BOMBAY AIR","hs_no":"29339990","bill_no":"1794384","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"MEXICO","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"Plot 170-172, Chandramouli Industrial Estate, Mohol Bazarpeth, Solapur","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q2","strtotime":1654021800,"product":"IMIQUIMOD. (*LUT ARN NO. AD240322035753E","address":"Plot 170-172, Chandramouli Industrial Estate, Mohol Bazarpeth","city":"Solapur","supplier":"GLENMARK PHARMACEUTICALS","supplierCountry":"INDIA","foreign_port":"GUARULHOS","customer":"TO THE ORDER","customerCountry":"BRAZIL","quantity":"4.00","actualQuantity":"4","unit":"KGS","unitRateFc":"2420","totalValueFC":"9536.6","currency":"USD","unitRateINR":186000,"date":"01-Jun-2022","totalValueINR":"744000","totalValueInUsd":"9536.6","indian_port":"BOMBAY AIR","hs_no":"29339990","bill_no":"1825568","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"BRAZIL","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"Plot 170-172, Chandramouli Industrial Estate, Mohol Bazarpeth, Solapur","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q2","strtotime":1655231400,"product":"IMIQUIMOD. (*LUT ARN NO. AD240322035753E","address":"Plot 170-172, Chandramouli Industrial Estate, Mohol Bazarpeth","city":"Solapur","supplier":"GLENMARK PHARMACEUTICALS","supplierCountry":"INDIA","foreign_port":"BOGOTA","customer":"TO THE ORDER","customerCountry":"COLOMBIA","quantity":"15.00","actualQuantity":"15","unit":"KGS","unitRateFc":"1400","totalValueFC":"20290.9","currency":"USD","unitRateINR":105533.33333333333,"date":"15-Jun-2022","totalValueINR":"1583000","totalValueInUsd":"20290.9","indian_port":"BOMBAY AIR","hs_no":"29339990","bill_no":"2132829","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"COLOMBIA","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"Plot 170-172, Chandramouli Industrial Estate, Mohol Bazarpeth, Solapur","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q2","strtotime":1655231400,"product":"IMIQUIMOD *LUT ARN NO. AD240322035753E D","address":"Plot 170-172, Chandramouli Industrial Estate, Mohol Bazarpeth","city":"Solapur","supplier":"GLENMARK PHARMACEUTICALS","supplierCountry":"INDIA","foreign_port":"MEXICO CITY","customer":"TO THE ORDER","customerCountry":"MEXICO","quantity":"5.00","actualQuantity":"5","unit":"KGS","unitRateFc":"2900","totalValueFC":"14266.4","currency":"USD","unitRateINR":222600,"date":"15-Jun-2022","totalValueINR":"1113000","totalValueInUsd":"14266.4","indian_port":"BOMBAY AIR","hs_no":"29339990","bill_no":"2147064","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"MEXICO","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"Plot 170-172, Chandramouli Industrial Estate, Mohol Bazarpeth, Solapur","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q3","strtotime":1660588200,"product":"IMIQUIMOD-UPS BATCH NO: MBPC21001A","address":"NO.201, DEVAVRATA SECTOR 17, VASHI, NAVI MUMBAI - 400705. Contac","city":"NAVI MUMBAI","supplier":"SOLARA ACTIVE PHARMA SCIENCES","supplierCountry":"INDIA","foreign_port":"TAIPEI","customer":"M\/S","customerCountry":"TAIWAN","quantity":"3.00","actualQuantity":"3","unit":"KGS","unitRateFc":"3600","totalValueFC":"10067","currency":"USD","unitRateINR":267000,"date":"16-Aug-2022","totalValueINR":"801000","totalValueInUsd":"10067","indian_port":"BANGALORE AIR","hs_no":"29420090","bill_no":"3514533","productDescription":"API","marketType":"REGULATED MARKET","country":"TAIWAN","selfForZScoreResived":"Pharma Grade","supplierPort":"BANGALORE AIR","supplierAddress":"NO.201, DEVAVRATA SECTOR 17, VASHI, NAVI MUMBAI - 400705. Contac, NAVI MUMBAI","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q3","strtotime":1661970600,"product":"IMIQUIMOD USP","address":"101, SAI SIDDHI BLDG, PLOT NO.264 H, SECTOR-3, AIROLI,","city":"NAVI MUMBAI, M.S.","supplier":"ZEON PHARMA INDUSTRIES INDIA PVT LTD","supplierCountry":"INDIA","foreign_port":"ASUNCION","customer":"BANCO BIBAO VIZCAYA","customerCountry":"PARAGUAY","quantity":"8.00","actualQuantity":"8","unit":"KGS","unitRateFc":"1250","totalValueFC":"9445.8","currency":"USD","unitRateINR":94625,"date":"01-Sep-2022","totalValueINR":"757000","totalValueInUsd":"9445.8","indian_port":"BOMBAY AIR","hs_no":"29339990","bill_no":"3888780","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"PARAGUAY","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"101, SAI SIDDHI BLDG, PLOT NO.264 H, SECTOR-3, AIROLI,, NAVI MUMBAI, M.S.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q3","strtotime":1663180200,"product":"IMIQUIMOD","address":"PLOT 170-172, CHANDRAMOULI,INDUSTR","city":"SOLAPUR,MAHARASHTRA","supplier":"GLENMARK PHARMACEUTICALS","supplierCountry":"INDIA","foreign_port":"BUENOS AIRES","customer":"MEGALABS","customerCountry":"ARGENTINA","quantity":"5.00","actualQuantity":"5","unit":"KGS","unitRateFc":"1396.5","totalValueFC":"6856.9","currency":"USD","unitRateINR":109904.60000000001,"date":"15-Sep-2022","totalValueINR":"549523","totalValueInUsd":"6856.9","indian_port":"Dahez-SEZ","hs_no":"29339990","bill_no":"4010668","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"ARGENTINA","selfForZScoreResived":"Pharma Grade","supplierPort":"Dahez-SEZ","supplierAddress":"PLOT 170-172, CHANDRAMOULI,INDUSTR, SOLAPUR,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q4","strtotime":1669746600,"product":"IMIQUIMOD - USP (BATCH NO.MBPC21001A, MF","address":"NO.201, DEVAVRATA SECTOR 17, VASHI, NAVI MUMBAI - 400705. Contac","city":"NAVI MUMBAI","supplier":"SOLARA ACTIVE PHARMA SCIENCES","supplierCountry":"INDIA","foreign_port":"DUBAI","customer":"M\/S,","customerCountry":"UNITED ARAB EMIRATES","quantity":"2.20","actualQuantity":"2.2","unit":"KGS","unitRateFc":"2649","totalValueFC":"4815.4","currency":"EUR","unitRateINR":178636.36363636362,"date":"30-Nov-2022","totalValueINR":"393000","totalValueInUsd":"4815.4","indian_port":"BOMBAY AIR","hs_no":"29420090","bill_no":"5833294","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"UNITED ARAB EMIRATES","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"NO.201, DEVAVRATA SECTOR 17, VASHI, NAVI MUMBAI - 400705. Contac, NAVI MUMBAI","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1674585000,"product":"IMIQUIMOD-USP BATCH NO: MBPC21001A","address":"NO.201, DEVAVRATA SECTOR 17, VASHI, NAVI MUMBAI - 400705. Contac","city":"NAVI MUMBAI","supplier":"SOLARA ACTIVE PHARMA SCIENCES","supplierCountry":"INDIA","foreign_port":"CAPE TOWN","customer":"M\/S","customerCountry":"SOUTH AFRICA","quantity":"0.25","actualQuantity":"0.25","unit":"KGS","unitRateFc":"4800","totalValueFC":"807.2","currency":"USD","unitRateINR":264000,"date":"25-Jan-2023","totalValueINR":"66000","totalValueInUsd":"807.2","indian_port":"BANGALORE AIR","hs_no":"29420090","bill_no":"7246507","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"SOUTH AFRICA","selfForZScoreResived":"Pharma Grade","supplierPort":"BANGALORE AIR","supplierAddress":"NO.201, DEVAVRATA SECTOR 17, VASHI, NAVI MUMBAI - 400705. Contac, NAVI MUMBAI","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q3","strtotime":1689100200,"product":"IMIQUIMOD-USP BATCH NO: MBPC21001A MFG D","address":"NO.201, DEVAVRATA SECTOR 17, VASHI, NAVI MUMBAI - 400705. Contac","city":"NAVI MUMBAI","supplier":"SOLARA ACTIVE PHARMA SCIENCES","supplierCountry":"INDIA","foreign_port":"ANKARA","customer":"M\/S","customerCountry":"TURKEY","quantity":"3.00","actualQuantity":"3","unit":"KGS","unitRateFc":"3800","totalValueFC":"11011.1","currency":"USD","unitRateINR":301666.63799999998,"date":"12-Jul-2023","totalValueINR":"904999.914","totalValueInUsd":"11011.1","indian_port":"BANGALORE AIR","hs_no":"29420090","bill_no":"0","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"TURKEY","selfForZScoreResived":"Pharma Grade","supplierPort":"BANGALORE AIR","supplierAddress":"NO.201, DEVAVRATA SECTOR 17, VASHI, NAVI MUMBAI - 400705. Contac, NAVI MUMBAI","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q3","strtotime":1691519400,"product":"IMIQUIMOD USP","address":"NA","city":"","supplier":"GLOBAUX IMPEX PRIVATE LIMITED","supplierCountry":"INDIA","foreign_port":"TORONTO","customer":"Z TO ORDER AND NA","customerCountry":"CANADA","quantity":"1.00","actualQuantity":"1","unit":"KGS","unitRateFc":"3100","totalValueFC":"3060.2","currency":"USD","unitRateINR":253491.96599999999,"date":"09-Aug-2023","totalValueINR":"253491.966","totalValueInUsd":"3060.2","indian_port":"AHMEDABAD AIR","hs_no":"29339990","bill_no":"0","productDescription":"API","marketType":"REGULATED MARKET","country":"CANADA","selfForZScoreResived":"Pharma Grade","supplierPort":"AHMEDABAD AIR","supplierAddress":"NA, ","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q3","strtotime":1691951400,"product":"IMIQUIMOD USP","address":"#N\/A","city":"","supplier":"GLOBAUX IMPEX PRIVATE LIMITED","supplierCountry":"INDIA","foreign_port":"TORONTO","customer":"Z TO ORDER AND NA","customerCountry":"CANADA","quantity":"1.00","actualQuantity":"1","unit":"KGS","unitRateFc":"3100","totalValueFC":"3060.2","currency":"USD","unitRateINR":253491.96599999999,"date":"14-Aug-2023","totalValueINR":"253491.966","totalValueInUsd":"3060.2","indian_port":"BOMBAY AIR","hs_no":"29339990","bill_no":"0","productDescription":"API","marketType":"REGULATED MARKET","country":"CANADA","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"#N\/A, ","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q3","strtotime":1693420200,"product":"IMIQUIMOD-USP BATCH NO:MBPC23001A MANUFACTURING DA","address":"NO.201 DEVAVRATA SECTOR 17VASHI - 400705.","city":"","supplier":"SOLARA ACTIVE PHARMA SCIENCES","supplierCountry":"INDIA","foreign_port":"ANKARA","customer":"MS","customerCountry":"TURKEY","quantity":"3.00","actualQuantity":"3","unit":"KGS","unitRateFc":"3800","totalValueFC":"10843.1","currency":"USD","unitRateINR":299400.07399999996,"date":"31-Aug-2023","totalValueINR":"898200.222","totalValueInUsd":"10843.1","indian_port":"BANGALORE AIR","hs_no":"29420090","bill_no":"0","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"TURKEY","selfForZScoreResived":"Pharma Grade","supplierPort":"BANGALORE AIR","supplierAddress":"NO.201 DEVAVRATA SECTOR 17VASHI - 400705., ","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q3","strtotime":1695148200,"product":"IMIQUIMOD-USP, BATCH NO. MBPC23001A , MFG DT-AUG,2023, RETEST DT- JUL,2028","address":"NO.201, DEVAVRATA SECTOR 17,,VASHI","city":"NAVI MUMBAI,MAHARASHTRA","supplier":"SOLARA ACTIVE PHARMA SCIENCES","supplierCountry":"INDIA","foreign_port":"DUBAI","customer":"KINGS MARQUE INTERNATIONAL ","customerCountry":"UNITED ARAB EMIRATES","quantity":"8.50","actualQuantity":"8.5","unit":"KGS","unitRateFc":"2600","totalValueFC":"23323","currency":"EUR","unitRateINR":227764.70588235295,"date":"20-Sep-2023","totalValueINR":"1936000","totalValueInUsd":"23323","indian_port":"Delhi Air","hs_no":"29420090","bill_no":"4043408","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"UNITED ARAB EMIRATES","selfForZScoreResived":"Pharma Grade","supplierPort":"Delhi Air","supplierAddress":"NO.201, DEVAVRATA SECTOR 17,,VASHI, NAVI MUMBAI,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q3","strtotime":1695925800,"product":"ACTIVE PHARMACEUTICALS INGREDIENTS (API)EXPORT INVOICE NUMBER : F32418002521 DT. 21.09.2023 IMIQUIMOD","address":"PLOT 170-172, CHANDRAMOULI,INDUSTR","city":"SOLAPUR,MAHARASHTRA","supplier":"GLENMARK PHARMACEUTICALS","supplierCountry":"INDIA","foreign_port":"GUARULHOS","customer":"TO THE ORDER","customerCountry":"BRAZIL","quantity":"4.00","actualQuantity":"4","unit":"KGS","unitRateFc":"2420","totalValueFC":"9601.5","currency":"USD","unitRateINR":199250,"date":"29-Sep-2023","totalValueINR":"797000","totalValueInUsd":"9601.5","indian_port":"Bombay Air","hs_no":"29339990","bill_no":"4292342","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"BRAZIL","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"PLOT 170-172, CHANDRAMOULI,INDUSTR, SOLAPUR,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1697135400,"product":"IMIQUIMOD-USP BATCH NO:MBPC23001A MFG DATE AUG 2023 RE TEST DATE JUL 2028","address":"NO.201, DEVAVRATA SECTOR 17,,VASHI","city":"NAVI MUMBAI,MAHARASHTRA","supplier":"SOLARA ACTIVE PHARMA SCIENCES","supplierCountry":"INDIA","foreign_port":"ISTANBUL","customer":"M\/S","customerCountry":"TURKEY","quantity":"6.00","actualQuantity":"6","unit":"KGS","unitRateFc":"3000","totalValueFC":"17217.5","currency":"USD","unitRateINR":238833.33333333334,"date":"13-Oct-2023","totalValueINR":"1433000","totalValueInUsd":"17217.5","indian_port":"Bangalore Air","hs_no":"29420090","bill_no":"4601603","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"TURKEY","selfForZScoreResived":"Pharma Grade","supplierPort":"Bangalore Air","supplierAddress":"NO.201, DEVAVRATA SECTOR 17,,VASHI, NAVI MUMBAI,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1698690600,"product":"IMIQUIMOD UPS BATCH NO:MBPC23001A MFG DATE AUG 2023 RE TEST DATE JUL 2028","address":"NO.201, DEVAVRATA SECTOR 17,,VASHI","city":"NAVI MUMBAI,MAHARASHTRA","supplier":"SOLARA ACTIVE PHARMA SCIENCES","supplierCountry":"INDIA","foreign_port":"TAIPEI","customer":"M\/S","customerCountry":"TAIWAN","quantity":"3.00","actualQuantity":"3","unit":"KGS","unitRateFc":"3600","totalValueFC":"10405","currency":"USD","unitRateINR":288666.66666666669,"date":"31-Oct-2023","totalValueINR":"866000","totalValueInUsd":"10405","indian_port":"Bangalore Air","hs_no":"29420090","bill_no":"5008152","productDescription":"API","marketType":"REGULATED MARKET","country":"TAIWAN","selfForZScoreResived":"Pharma Grade","supplierPort":"Bangalore Air","supplierAddress":"NO.201, DEVAVRATA SECTOR 17,,VASHI, NAVI MUMBAI,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1700073000,"product":"IMIQUIMOD USP","address":"NO.201, DEVAVRATA SECTOR 17,,VASHI","city":"NAVI MUMBAI,MAHARASHTRA","supplier":"SOLARA ACTIVE PHARMA SCIENCES","supplierCountry":"INDIA","foreign_port":"PARIS - CHARLES DE G","customer":"M\/S","customerCountry":"FRANCE","quantity":"1.00","actualQuantity":"1","unit":"KGS","unitRateFc":"6500","totalValueFC":"5836.4","currency":"USD","unitRateINR":486000,"date":"16-Nov-2023","totalValueINR":"486000","totalValueInUsd":"5836.4","indian_port":"Bangalore Air","hs_no":"29420090","bill_no":"5368138","productDescription":"API","marketType":"REGULATED MARKET","country":"FRANCE","selfForZScoreResived":"Pharma Grade","supplierPort":"Bangalore Air","supplierAddress":"NO.201, DEVAVRATA SECTOR 17,,VASHI, NAVI MUMBAI,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1701109800,"product":"IMIQUIMOD USP BATCH NO. 21002838","address":"B.S.D.MARG, GOVANDI STATION ROAD,","city":"MUMBAI, MAHARASHTRA.","supplier":"USV PRIVATE LIMITED","supplierCountry":"INDIA","foreign_port":"ISTANBUL","customer":"VEM PHARMACEUTICALS","customerCountry":"TURKEY","quantity":"5.00","actualQuantity":"5","unit":"KGS","unitRateFc":"4750","totalValueFC":"23429.6","currency":"USD","unitRateINR":390200,"date":"28-Nov-2023","totalValueINR":"1951000","totalValueInUsd":"23429.6","indian_port":"Bombay Air","hs_no":"29359090","bill_no":"5643199","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"TURKEY","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"B.S.D.MARG, GOVANDI STATION ROAD,, MUMBAI, MAHARASHTRA.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1706121000,"product":"ACTIVE PHARMACEUTICALS INGREDIENTS (API) EXPORT INVOICE NUMBER : F32418004415 DT. 24.01.2024 IMIQUIMOD","address":"PLOT 170-172, CHANDRAMOULI,INDUSTR","city":"SOLAPUR,MAHARASHTRA","supplier":"GLENMARK PHARMACEUTICALS","supplierCountry":"INDIA","foreign_port":"MIAMI, FL","customer":"TO THE ORDER","customerCountry":"UNITED STATES","quantity":"2.00","actualQuantity":"2","unit":"KGS","unitRateFc":"4000","totalValueFC":"7844.6","currency":"USD","unitRateINR":325987,"date":"25-Jan-2024","totalValueINR":"651974","totalValueInUsd":"7844.6","indian_port":"Bombay Air","hs_no":"29339990","bill_no":"7011209","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"PLOT 170-172, CHANDRAMOULI,INDUSTR, SOLAPUR,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1711045800,"product":"IMIQUIMOD USP","address":"101, SAI SIDDHI BLDG, PLOT","city":"NAVI MUMBAI, M.S.","supplier":"ZEON PHARMA INDUSTRIES INDIA PVT LTD","supplierCountry":"INDIA","foreign_port":"ASUNCION","customer":"BANCO BIBAO VIZCAYA","customerCountry":"PARAGUAY","quantity":"10.00","actualQuantity":"10","unit":"KGS","unitRateFc":"1200","totalValueFC":"11525.1","currency":"USD","unitRateINR":95699.917000000001,"date":"22-Mar-2024","totalValueINR":"956999.17","totalValueInUsd":"11525.1","indian_port":"Bombay Air","hs_no":"29339990","bill_no":"8567373","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"PARAGUAY","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"101, SAI SIDDHI BLDG, PLOT, NAVI MUMBAI, M.S.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1711564200,"product":"IMIQUIMOD-USP BATCH NO:MBPC23001A ,24001A MFG DT:AUG 2023,FEB 2024 RE TEST DT:JULY 2028,JAN 2029","address":"NO.201, DEVAVRATA SECTOR 17,,VASHI","city":"NAVI MUMBAI,MAHARASHTRA","supplier":"SOLARA ACTIVE PHARMA SCIENCES","supplierCountry":"INDIA","foreign_port":"ISTANBUL","customer":"M\/S","customerCountry":"TURKEY","quantity":"6.00","actualQuantity":"6","unit":"KGS","unitRateFc":"2750","totalValueFC":"15151.4","currency":"USD","unitRateINR":209685.40833333333,"date":"28-Mar-2024","totalValueINR":"1258112.45","totalValueInUsd":"15151.4","indian_port":"Bangalore Air","hs_no":"29420090","bill_no":"8711822","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"TURKEY","selfForZScoreResived":"Pharma Grade","supplierPort":"Bangalore Air","supplierAddress":"NO.201, DEVAVRATA SECTOR 17,,VASHI, NAVI MUMBAI,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1718303400,"product":"IMIQUIMOD USP","address":"4A, AMAN ADHAR SOCIETY","city":"VADODARA","supplier":"GLOBAUX IMPEX PRIVATE LIMITED","supplierCountry":"INDIA","foreign_port":"TORONTO","customer":"TO THE ORDER OF","customerCountry":"CANADA","quantity":"2.00","actualQuantity":"2","unit":"KGS","unitRateFc":"4300","totalValueFC":"8311.5","currency":"USD","unitRateINR":346920,"date":"14-Jun-2024","totalValueINR":"693840","totalValueInUsd":"8311.5","indian_port":"Ahmedabad Air","hs_no":"29339990","bill_no":"1678590","productDescription":"API","marketType":"REGULATED MARKET","country":"CANADA","selfForZScoreResived":"Pharma Grade","supplierPort":"Ahmedabad Air","supplierAddress":"4A, AMAN ADHAR SOCIETY, VADODARA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1721241000,"product":"ACTIVE PHARMACEUTICALS INGREDIENTS (API)EXPORT INVOICE NUMBER : F32518001475 DT. 12.07.2024 IMIQUIMOD","address":"PLOT 170-172, CHANDRAMOULI,INDUSTR","city":"SOLAPUR,MAHARASHTRA","supplier":"GLENMARK PHARMACEUTICALS","supplierCountry":"INDIA","foreign_port":"GUARULHOS","customer":"TO THE ORDER","customerCountry":"BRAZIL","quantity":"3.00","actualQuantity":"3","unit":"KGS","unitRateFc":"2420","totalValueFC":"7182.6","currency":"USD","unitRateINR":200134,"date":"18-Jul-2024","totalValueINR":"600402","totalValueInUsd":"7182.6","indian_port":"Bombay Air","hs_no":"29339990","bill_no":"2525247","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"BRAZIL","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"PLOT 170-172, CHANDRAMOULI,INDUSTR, SOLAPUR,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1723055400,"product":"IMIQUIMOD - USP","address":"NO.201, DEVAVRATA SECTOR 17,,VASHI","city":"NAVI MUMBAI,MAHARASHTRA","supplier":"SOLARA ACTIVE PHARMA SCIENCES","supplierCountry":"INDIA","foreign_port":"DUBAI","customer":"M\/S,","customerCountry":"UNITED ARAB EMIRATES","quantity":"5.00","actualQuantity":"5","unit":"KGS","unitRateFc":"2400","totalValueFC":"12754.2","currency":"EUR","unitRateINR":213960,"date":"08-Aug-2024","totalValueINR":"1069800","totalValueInUsd":"12754.2","indian_port":"Bombay Air","hs_no":"29420090","bill_no":"3050174","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"UNITED ARAB EMIRATES","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"NO.201, DEVAVRATA SECTOR 17,,VASHI, NAVI MUMBAI,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1724697000,"product":"ACTIVE PHARMACEUTICALS INGREDIENTS (API)EXPORT INVOICE NUMBER: F32518001884 DT.20.08.2024 IMIQUIMOD","address":"PLOT 170-172, CHANDRAMOULI,INDUSTR","city":"SOLAPUR,MAHARASHTRA","supplier":"GLENMARK PHARMACEUTICALS","supplierCountry":"INDIA","foreign_port":"GUARULHOS","customer":"TO THE ORDER","customerCountry":"BRAZIL","quantity":"2.00","actualQuantity":"2","unit":"KGS","unitRateFc":"2420","totalValueFC":"4795.1","currency":"USD","unitRateINR":201102,"date":"27-Aug-2024","totalValueINR":"402204","totalValueInUsd":"4795.1","indian_port":"Bombay Air","hs_no":"29339990","bill_no":"3513189","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"BRAZIL","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"PLOT 170-172, CHANDRAMOULI,INDUSTR, SOLAPUR,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1727634600,"product":"ACTIVE PHARMACEUTICALS INGREDIENTS (API) EXPORT INVOICE NUMBER : F32518002520 DT. 28.09.2024 IMIQUIMOD","address":"PLOT 170-172, CHANDRAMOULI,INDUSTR","city":"SOLAPUR,MAHARASHTRA","supplier":"GLENMARK PHARMACEUTICALS","supplierCountry":"INDIA","foreign_port":"MEXICO CITY","customer":"TO THE ORDER","customerCountry":"MEXICO","quantity":"5.00","actualQuantity":"5","unit":"KGS","unitRateFc":"2900","totalValueFC":"14221","currency":"USD","unitRateINR":238348,"date":"30-Sep-2024","totalValueINR":"1191740","totalValueInUsd":"14221","indian_port":"Bombay Air","hs_no":"29339990","bill_no":"4457573","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"MEXICO","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"PLOT 170-172, CHANDRAMOULI,INDUSTR, SOLAPUR,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1729621800,"product":"ACTIVE PHARMACEUTICALS INGREDIENTS (API)EXPORT INVOICE NUMBER : F32518002841 DT. 21.10.2024 IMIQUIMOD","address":"PLOT 170-172, CHANDRAMOULI,INDUSTR","city":"SOLAPUR,MAHARASHTRA","supplier":"GLENMARK PHARMACEUTICALS","supplierCountry":"INDIA","foreign_port":"GUARULHOS","customer":"TO THE ORDER","customerCountry":"BRAZIL","quantity":"3.00","actualQuantity":"3","unit":"KGS","unitRateFc":"2420","totalValueFC":"7188.6","currency":"USD","unitRateINR":201344,"date":"23-Oct-2024","totalValueINR":"604032","totalValueInUsd":"7188.6","indian_port":"Bombay Air","hs_no":"29339990","bill_no":"5044913","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"BRAZIL","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"PLOT 170-172, CHANDRAMOULI,INDUSTR, SOLAPUR,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1729621800,"product":"ACTIVE PHARMACEUTICALS INGREDIENTS (API)EXPORT INVOICE NUMBER : F32518002842 DT. 21.10.2024 IMIQUIMOD","address":"PLOT 170-172, CHANDRAMOULI,INDUSTR","city":"SOLAPUR,MAHARASHTRA","supplier":"GLENMARK PHARMACEUTICALS","supplierCountry":"INDIA","foreign_port":"GUARULHOS","customer":"TO THE ORDER","customerCountry":"BRAZIL","quantity":"2.00","actualQuantity":"2","unit":"KGS","unitRateFc":"2420","totalValueFC":"4792.4","currency":"USD","unitRateINR":201344,"date":"23-Oct-2024","totalValueINR":"402688","totalValueInUsd":"4792.4","indian_port":"Bombay Air","hs_no":"29339990","bill_no":"5066067","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"BRAZIL","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"PLOT 170-172, CHANDRAMOULI,INDUSTR, SOLAPUR,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1729881000,"product":"ACTIVE PHARMACEUTICALS INGREDIENTS (API)EXPORT INVOICE NUMBER : F32512200804 DT25.10.2024 IMIQUIMOD USP","address":"PLOT 170-172, CHANDRAMOULI,INDUSTR","city":"SOLAPUR,MAHARASHTRA","supplier":"GLENMARK PHARMACEUTICALS","supplierCountry":"INDIA","foreign_port":"BUENOS AIRES","customer":"TO THE ORDER","customerCountry":"ARGENTINA","quantity":"15.00","actualQuantity":"15","unit":"KGS","unitRateFc":"1150","totalValueFC":"16832.8","currency":"USD","unitRateINR":94293.333333333328,"date":"26-Oct-2024","totalValueINR":"1414400","totalValueInUsd":"16832.8","indian_port":"Dahez-SEZ","hs_no":"29339990","bill_no":"5163710","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"ARGENTINA","selfForZScoreResived":"Pharma Grade","supplierPort":"Dahez-SEZ","supplierAddress":"PLOT 170-172, CHANDRAMOULI,INDUSTR, SOLAPUR,MAHARASHTRA","customerAddress":""},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q2","strtotime":1649874600,"product":"IMIQUIMOD (QTY:1X200 MG,PRICE: USD 252)(FOC)","address":"P.NO. D6 & D8, SY.NO. 234\/2,234\/3, ,235\/2 & 542\/2, IKP KNOWLEDGE PARK,","city":"TURKAPALLY-V SHAMIRPET HYDERABAD,TE","supplier":"USP","supplierCountry":"INDIA","foreign_port":"NA","customer":"UNITED STATES PHARMACOPEIA - INDIA PRIVATE LIMITED","customerCountry":"INDIA","quantity":"0.00","actualQuantity":"0.0002","unit":"KGS","unitRateFc":"1260000","totalValueFC":"263.7","currency":"USD","unitRateINR":"99468650","date":"14-Apr-2022","totalValueINR":"19893.73","totalValueInUsd":"263.7","indian_port":"HYDERABAD AIR","hs_no":"29339990","bill_no":"8276555","productDescription":"Re-Import","marketType":"REGULATED MARKET","country":"INDIA","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"P.NO. D6 & D8, SY.NO. 234\/2,234\/3, ,235\/2 & 542\/2, IKP KNOWLEDGE PARK,"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q2","strtotime":1649874600,"product":"IMIQUIMOD RELATED COMPOUND A (QTY:1X25 MG,PRICE: USD 860)(FOC)","address":"P.NO. D6 & D8, SY.NO. 234\/2,234\/3, ,235\/2 & 542\/2, IKP KNOWLEDGE PARK,","city":"TURKAPALLY-V SHAMIRPET HYDERABAD,TE","supplier":"USP","supplierCountry":"INDIA","foreign_port":"NA","customer":"UNITED STATES PHARMACOPEIA - INDIA PRIVATE LIMITED","customerCountry":"INDIA","quantity":"0.00","actualQuantity":"0.000025","unit":"KGS","unitRateFc":"34400000","totalValueFC":"899.8","currency":"USD","unitRateINR":"2715651600","date":"14-Apr-2022","totalValueINR":"67891.29","totalValueInUsd":"899.8","indian_port":"HYDERABAD AIR","hs_no":"29339990","bill_no":"8276555","productDescription":"Re-Import","marketType":"REGULATED MARKET","country":"INDIA","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"P.NO. D6 & D8, SY.NO. 234\/2,234\/3, ,235\/2 & 542\/2, IKP KNOWLEDGE PARK,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1725993000,"product":"IMIQUIMOD (IMIQUIMOD USP)","address":"UNIT NO.24 STEEL MADE INDL.ESTATE","city":"MUMBAI","supplier":"INTERQUIM SA","supplierCountry":"SPAIN","foreign_port":"BARCELONA","customer":"ENCUBE ETHICALS PRIVATE LIMITED","customerCountry":"INDIA","quantity":"5.00","actualQuantity":"5","unit":"KGS","unitRateFc":"10500","totalValueFC":"59359.2","currency":"EUR","unitRateINR":"994875","date":"11-Sep-2024","totalValueINR":"4974375","totalValueInUsd":"59359.2","indian_port":"Bombay Air","hs_no":"29339990","bill_no":"5548962","productDescription":"API","marketType":"REGULATED MARKET","country":"SPAIN","selfForZScoreResived":"Pharma Grade","supplierPort":"BARCELONA","supplierAddress":"JOAN BUSCALLA, 10 08173 SANT CUGAT DEL VALLES BARCELONA ES","customerAddress":"UNIT NO.24 STEEL MADE INDL.ESTATE"}]

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API Imports and Exports

Importing Country	Total Quantity (KGS)	Average Price (USD/KGS)	Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

Drugs in Development

Full Screen View

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

INTERMEDIATES SUPPLIERS

Full Screen View

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDF Dossiers

Full Screen View

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDA Orange Book

Full Screen View

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Europe

Full Screen View

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Canada

Full Screen View

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Australia

Full Screen View

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

South Africa

Full Screen View

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Dossiers

Full Screen View

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Topical

Solubilizers

Thickeners and Stabilizers

Emulsifying Agents

Parenteral

Surfactant & Foaming Agents

Rheology Modifiers

API Stability Enhancers

Film Formers & Plasticizers

Granulation

Controlled & Modified Release

Direct Compression

Lubricants & Glidants

Coating Systems & Additives

Digital Content

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

NEWS #PharmaBuzz

Global Sales Information

Do you need Business Intel? Ask us

US Medicaid Prescriptions

Full Screen View

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Finished Drug Prices

Full Screen View

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Market Place

Do you need sourcing support? Ask us

APIs

Full Screen View

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDF DOSSIERS

Full Screen View

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

US Patents

Full Screen View

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Health Canada Patents

Full Screen View

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

USP

Others

Full Screen View

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

ABOUT THIS PAGE

Imiquimod Manufacturers

A Imiquimod manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Imiquimod, including repackagers and relabelers. The FDA regulates Imiquimod manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Imiquimod API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Imiquimod manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Imiquimod Suppliers

A Imiquimod supplier is an individual or a company that provides Imiquimod active pharmaceutical ingredient (API) or Imiquimod finished formulations upon request. The Imiquimod suppliers may include Imiquimod API manufacturers, exporters, distributors and traders.

click here to find a list of Imiquimod suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Imiquimod USDMF

A Imiquimod DMF (Drug Master File) is a document detailing the whole manufacturing process of Imiquimod active pharmaceutical ingredient (API) in detail. Different forms of Imiquimod DMFs exist exist since differing nations have different regulations, such as Imiquimod USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Imiquimod DMF submitted to regulatory agencies in the US is known as a USDMF. Imiquimod USDMF includes data on Imiquimod's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Imiquimod USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Imiquimod suppliers with USDMF on PharmaCompass.

Imiquimod KDMF

In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.

Pharmaceutical companies submit a Imiquimod Drug Master File in Korea (Imiquimod KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Imiquimod. The MFDS reviews the Imiquimod KDMF as part of the drug registration process and uses the information provided in the Imiquimod KDMF to evaluate the safety and efficacy of the drug.

After submitting a Imiquimod KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Imiquimod API can apply through the Korea Drug Master File (KDMF).

click here to find a list of Imiquimod suppliers with KDMF on PharmaCompass.

Imiquimod WC

A Imiquimod written confirmation (Imiquimod WC) is an official document issued by a regulatory agency to a Imiquimod manufacturer, verifying that the manufacturing facility of a Imiquimod active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Imiquimod APIs or Imiquimod finished pharmaceutical products to another nation, regulatory agencies frequently require a Imiquimod WC (written confirmation) as part of the regulatory process.

click here to find a list of Imiquimod suppliers with Written Confirmation (WC) on PharmaCompass.

Imiquimod NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Imiquimod as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Imiquimod API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Imiquimod as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Imiquimod and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Imiquimod NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Imiquimod suppliers with NDC on PharmaCompass.

Imiquimod GMP

Imiquimod Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Imiquimod GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Imiquimod GMP manufacturer or Imiquimod GMP API supplier for your needs.

Imiquimod CoA

A Imiquimod CoA (Certificate of Analysis) is a formal document that attests to Imiquimod's compliance with Imiquimod specifications and serves as a tool for batch-level quality control.

Imiquimod CoA mostly includes findings from lab analyses of a specific batch. For each Imiquimod CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Imiquimod may be tested according to a variety of international standards, such as European Pharmacopoeia (Imiquimod EP), Imiquimod JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Imiquimod USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.

Market Place

Home

Menu

Post Enquiry

Market Place

Search